An innovation launched this company
Little Green Pharma was founded in 2016 with the aims of improving the quality of life for a child debilitated by seizures using the company’s patented small-particle formulation and to take advantage of opportunities in the emerging medicinal cannabis industry in Australia and overseas.
Since then, the company has invested significantly into product development, sales and marketing and cultivation capabilities with the aim of becoming a leading Australian and Global medicinal cannabis company and achieved the following milestones:
April 2017
License to cultivate and produce Medicinal Cannabis granted by the Federal Office of Drug Control (ODC) in Australia
December 2017
LGP’s first crop of Medicinal Cannabis started cultivation in Western Australia
March 2018
LGP granted a patent for its small particle liposomal delivery system
April 2018
Australia’s first crop of Medicinal Cannabis for commercial use harvested
August 2018
First Australian-grown cannabis medicines available to Australian patients
January 2019
Export License granted by the Federal Department of Health
2019
Signed agreements with organisations in Germany, Canada and NZ
October 2020
Little Green Pharma granted Therapeutic Goods Administration (TGA) Good Manufacturing Practices (GMP) licence
November 2020
First Australian Medicinal Cannabis Oil Exported to Germany
January 2021
LGP appointed as a primary medicinal cannabis oil manufacturer for national French medicinal cannabis
June 2021
LGP acquires world-class, fully operational GACP cultivation and GMP licensed medicinal cannabis asset in Denmark (EU)
September 2021
LGP granted Schedule 9 licence to supply psilocybin by WA Government Department of Health (beginnings of psychedelics separate unlisted entity, Reset Mind Sciences Ltd)
November 2021
LGP secures first registration for locally produced cannabis medicine In Denmark.
January 2022
LGP signs four-year agreement with PharmaServe for the distribution of LGP-branded oil medicines and cannabis flower in Greece.
February 2022
LGP awarded Government tender for medicinal cannabis flower from its Danish Facility into Italy.
April 2022
LGP signs three-year sales agreement with Deutsche Medizinalcannabis GmbH (Demecan), one of Germany’s largest cannabis distributors.
May 2022
LGP enters into a medicinal cannabis distribution agreement with Sana Life Sciences Ltd for the supply of LGP branded products for distribution in the United Kingdom and UK crown dependences.
